pharma news

News

Dr Ken Macnamara, Trogenix's chief executive

UK's Trogenix raises £70m for cancer immunotherapy platform

Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

News

Roche gets EU nod for kidney disease algorithm

Roche and Klinrisk have picked up a CE-mark for an AI tool that can be used to predict renal function decline in patients with chronic kidney disease.

News

Delayed TNBC readout for Datroway delivers survival benefit

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

News

Pills piled together in the shape of the USA

FDA pilots fast-track scheme for US-made generics

In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.

News

Rocket aborts FDA filing for Fanconi gene therapy

Rocket Pharma has withdrawn a filing in the US for its experimental gene therapy for Fanconi anaemia, but may consider partnering the programme.

News

Cidara gets $339m BARDA award for flu prophylactic

Cidara is celebrating a major injection of funding from the US government for its experimental one-shot, universal flu prophylactic CD388.

UK's Trogenix raises £70m for cancer immunotherapy platform

Roche gets EU nod for kidney disease algorithm

Delayed TNBC readout for Datroway delivers survival benefit

FDA pilots fast-track scheme for US-made generics

Rocket aborts FDA filing for Fanconi gene therapy

Cidara gets $339m BARDA award for flu prophylactic

ASCO 2026: AbbVie on ADCs, chemotherapy, and the future of o...

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks